These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10996382)

  • 1. Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.
    Beagley KW; Timms P
    J Reprod Immunol; 2000 Aug; 48(1):47-68. PubMed ID: 10996382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
    Igietseme JU; Murdin A
    Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a Chlamydia trachomatis vaccine: how close are we?
    Cochrane M; Armitage CW; O'Meara CP; Beagley KW
    Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
    Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
    Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Variable Domain 4 Linear Epitopes of the
    Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlamydia trachomatis antigens: role in immunity and pathogenesis.
    Brunham RC; Peeling RW
    Infect Agents Dis; 1994 Oct; 3(5):218-33. PubMed ID: 7866655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
    Rey-Ladino J; Ross AG; Cripps AW
    Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H; Parnell M; Caldwell HD
    Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against Chlamydia: approaches and progress.
    Stagg AJ
    Mol Med Today; 1998 Apr; 4(4):166-73. PubMed ID: 9572058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development status and future prospects for a vaccine against Chlamydia trachomatis infection.
    Hafner LM; Wilson DP; Timms P
    Vaccine; 2014 Mar; 32(14):1563-71. PubMed ID: 23973245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With
    Nguyen NDNT; Guleed S; Olsen AW; Follmann F; Christensen JP; Dietrich J
    Front Immunol; 2021; 12():790463. PubMed ID: 34925371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.
    Vasilevsky S; Stojanov M; Greub G; Baud D
    Virulence; 2016; 7(1):11-22. PubMed ID: 26580416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
    Poston TB; Darville T
    Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
    Andrew DW; Hafner LM; Beagley KW; Timms P
    J Reprod Immunol; 2011 Sep; 91(1-2):9-16. PubMed ID: 21856018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
    He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
    Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance.
    Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P
    PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.
    Shaw J; Grund V; Durling L; Crane D; Caldwell HD
    Infect Immun; 2002 Mar; 70(3):1097-105. PubMed ID: 11854188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.